Jones Financial Companies
DYN icon

Jones Financial Companies’s Dyne Therapeutics DYN Stock Holding History

Jones Financial Companies’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Buy
4,928
+448
+10% +$8.33K ﹤0.01% 2846
2026
Q1 		$76.8K Buy
4,480
+3,281
+274% +$56.6K ﹤0.01% 2780
2025
Q4 		$23.5K Hold
1,199
– – ﹤0.01% 2864
2025
Q3 		$15.8K Hold
1,199
– – ﹤0.01% 2906
2025
Q2 		$11.5K Hold
1,199
– – ﹤0.01% 2818
2025
Q1 		$13.7K Buy
+1,199
New +$17.2K ﹤0.01% 2576

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jones Financial Companies's DYN Position: Q2 2026 in Review

Jones Financial Companies increased its Dyne Therapeutics (DYN) stake by 10% in Q2 2026, buying an estimated $8.33K and bringing the position to 4,928 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #2846.

Jones Financial Companies first reported a position in DYN in Q1 2025 and has held it in 6 quarters since. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Jones Financial Companies held 4,928 shares of Dyne Therapeutics worth $103K as of Q2 2026.
  • Jones Financial Companies bought 448 Dyne Therapeutics shares in Q2 2026, an estimated $8.33K.
  • Dyne Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2846 holding.
  • Jones Financial Companies first reported a position in Dyne Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.